Dyk Kathleen Van, Crespi Catherine M, Petersen Laura, Ganz Patricia A
See the Notes section for the full list of authors' affiliations.
JNCI Cancer Spectr. 2019 Nov 29;4(1):pkz099. doi: 10.1093/jncics/pkz099. eCollection 2020 Feb.
Cancer-related cognitive impairment (CRCI) is a concerning problem for many cancer survivors. Evaluating patients for CRCI has been a challenge, in part because of a lack of standardized practices. Self-report instruments are often used to assess CRCI, but there are no validated cutpoints. We present the results of receiver operating characteristic curve analysis identifying cutpoints of the Functional Assessment of Cancer Therapy-Cognition perceived cognitive impairment (PCI) in female breast cancer survivors for identifying CRCI cases. We defined presence of CRCI based on elevated complaints on the Patient's Assessment of Own Functioning Inventory compared with healthy control scores. Our results indicate that scores less than 54 in PCI scores using 18 items and scores less than 60 in PCI scores using 20 items exhibited good ability to discriminate CRCI cases from noncases (area under the receiver operating characteristic curve was 0.84 [95% CI = 0.73 to 0.94]). These preliminary results represent an important contribution toward standardizing practices across CRCI studies.
癌症相关认知障碍(CRCI)是许多癌症幸存者面临的一个令人担忧的问题。评估患者是否患有CRCI一直是一项挑战,部分原因是缺乏标准化的做法。自我报告工具常被用于评估CRCI,但尚无经过验证的切点。我们展示了接受者操作特征曲线分析的结果,该分析确定了女性乳腺癌幸存者中癌症治疗认知功能评估感知认知障碍(PCI)的切点,以识别CRCI病例。我们根据患者自我功能评估量表上与健康对照分数相比升高的主诉来定义CRCI的存在。我们的结果表明,使用18项条目的PCI得分低于54分以及使用20项条目的PCI得分低于60分,具有良好的区分CRCI病例与非病例的能力(接受者操作特征曲线下面积为0.84 [95% CI = 0.73至0.94])。这些初步结果对CRCI研究的标准化做法做出了重要贡献。